Biomedicines (Oct 2022)

Bronchial Asthma as a Cardiovascular Risk Factor: A Prospective Observational Study

  • Marcela Kreslová,
  • Olga Kirchnerová,
  • Daniel Rajdl,
  • Vendula Sudová,
  • Jiří Blažek,
  • Aneta Sýkorová,
  • Petr Jehlička,
  • Ladislav Trefil,
  • Jan Schwarz,
  • Renata Pomahačová,
  • Josef Sýkora

DOI
https://doi.org/10.3390/biomedicines10102614
Journal volume & issue
Vol. 10, no. 10
p. 2614

Abstract

Read online

Introduction: Asthma as a chronic inflammatory disorder has been suggested as a risk factor for endothelial dysfunction (ED), but studies on the association between asthma and cardiovascular disease (CVD) risk are limited. Background: We assessed associations of ED with the severity of asthma, eosinophilic inflammation, lung function, and asthma control. Methods: 52 young asthmatics (median age of 25.22 years) and 45 healthy individuals were included. Demographic, clinical, and laboratory findings were recorded. We evaluated microvascular responsiveness by recording the reactive hyperemia index (RHI) indicating post-occlusive peripheral endothelium-dependent changes in vascular tone using the Itamar Medical EndoPAT2000. VCAM-1, ADMA, high-sensitive CRP (hsCRP), and E-selectin were measured. Results: Asthmatics had considerably lower RHI values (p p p p < 0.001), especially in women and in severe asthma. Conclusions: We demonstrated the progression of CVD in asthmatics and the association of the ongoing deterioration of ED with the inflammatory severity, suggesting that the increased risk of CVD in young asthmatics is dependent on disease severity. The underlying mechanisms of risk factors for CVD and disease control require further study.

Keywords